Vir Biotechnology (NASDAQ:VIR) reported quarterly losses of $(0.85) per share. This is a 3.41 percent increase over losses of $(0.88) per share from the same period last year. The company reported $(29.000 thousand) in sales this quarter. This is a 100.96 percent decrease over sales of $3.032 million the same period last year.